Ursodeoxycholic acid for stomach precancer reversal
Treatments studied
Part of Digestive system clinical trials.
This trial tests if ursodeoxycholic acid can reverse intestinal metaplasia (a precancerous stomach condition) in patients who have no H. pylori infection. The goal is to see if this medication can help lower the risk of stomach cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 to 75 years
- Diagnosed with a moderate to advanced stage of stomach precancer (OLGIM stage II–IV) in the last 3 months
- No current H. pylori infection (must have been treated if previously infected)
- Not regularly taking NSAID pain relievers or statins
- No prior stomach surgery or cancer diagnosis
- No severe heart, kidney, or liver disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether berberine, a natural compound, can help reverse or slow the progression of gastric intestinal metaplasia, a precancerous condition in the stomach lining. Participation involves taking the medication and monitoring your stomach health over time.
This trial tests whether a treatment can reverse stomach lining changes called GIM that increase cancer risk. It's for people who have had a past H. pylori infection but no current stomach cancer, and whose GIM has certain high-risk features.
This study tests if Weifuchun tablets can reverse precancerous changes called gastric intestinal metaplasia. If you have this condition and no H. pylori infection, you may qualify.
This study tests a medicine called pyrvinium to see if it can reverse early changes in the stomach lining that may lead to stomach cancer. It may help prevent stomach cancer from developing.
This study tests whether taking a bile acid pill (ursodeoxycholic acid) during treatment for Barrett's esophagus can help the esophagus heal better after standard endoscopic therapy. It may reduce the chance of precancerous cells returning.
This trial tests whether ursodeoxycholic acid (a bile medicine) can help prevent complications from gallstone-related acute pancreatitis from coming back after you leave the hospital. It may help reduce repeat problems linked to gallstones, especially after an initial pancreatitis episode.
Hear when a new Gastric Intestinal Metaplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.